Equine Healthcare Market by Product Type (Drug, Vaccines, and Medicated Feed Additives), Disease (Influenza, Tetanus, Equine Herpes Virus, and Others), and Distribution Channel (Veterinary Hospitals and Clinics and Retail Pharmacies and Drug Stores): Opportunity Analysis and Industry Forecast, 2020–2030

1.1.Report description

1.2.Key Benefits for Stakeholders

1.3.Key market segments

1.3.1.List of key players profiled in the report

1.4.Research methodology

1.4.1.Secondary research

1.4.2.Primary research

1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

2.1.Key findings of the study

2.2.CXO perspective

CHAPTER 3:MARKET LANDSCAPE

3.1.Market definition and scope

3.2.Key findings

3.2.1.Top investment pockets

3.2.2.Top winning strategies

3.3.Porter’s five force analysis

3.4.Top player positioning, 2020

3.5.Market dynamics

3.5.1.Drivers

3.5.1.1.Increase in prevalence of equine diseases

3.5.1.2.Rise in animal health expenditure

3.5.2.Restraint

3.5.2.1.Decline in global equine population

3.5.3.Opportunities

3.5.3.1.Rise in demand for pet insurance

3.5.4.Impact analysis

3.6.COVID-19 Impact Analysis on Equine healthcare Market

CHAPTER 4:EQUINE HEALTHCARE MARKET, BY PRODUCT

4.1.Overview

4.1.1.Market size and forecast

4.2.Drug

4.2.1.Key market trends, growth factors, and opportunities

4.2.2.Market size and forecast, by region

4.2.3.Market analysis, by country

4.2.4.Anti-infectives Drugs

4.2.4.1.Market size and forecast

4.2.5.Anti-Inflammatory Drugs

4.2.5.1.Market size and forecast

4.2.6.Parasiticide Drugs

4.2.6.1.Market size and forecast

4.2.7.Other Drugs

4.2.7.1.Market size and forecast

4.3.Vaccines

4.3.1.Key market trends, growth factors, and opportunities

4.3.2.Market size and forecast

4.3.3.Market analysis, by country

4.3.4.Inactivated Vaccines

4.3.4.1.Market size and forecast

4.3.5.Live Attenuated Vaccine

4.3.5.1.Market size and forecast

4.3.6.Recombinant Vaccine

4.3.6.1.Market size and forecast

4.3.7.Other vaccines

4.3.7.1.Market size and forecast

4.4.Medicated feed additives

4.4.1.Key market trends, growth factors, and opportunities

4.4.2.Market size and forecast

4.4.3.Market analysis, by country

CHAPTER 5:EQUINE HEALTHCARE MARKET, BY DISEASES

5.1.Overview

5.1.1.Market size and forecast

5.2.Influenza

5.2.1.Market size and forecast, by region

5.2.2.Market analysis, by country

5.3.Tetanus

5.3.1.Market size and forecast, by region

5.3.2.Market analysis, by country

5.4.Equine Herpes Virus

5.4.1.Market size and forecast, by region

5.4.2.Market analysis, by country

5.5.Other diseases

5.5.1.Market size and forecast, by region

5.5.2.Market analysis, by country

CHAPTER 6:EQUINE HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL

6.1.Overview

6.1.1.Market size and forecast

6.2.Veterinary Hospitals and Clinics

6.2.1.Market size and forecast, by region

6.2.2.Market analysis, by country

6.3.Retail pharmacies and Drug Stores

6.3.1.Market size and forecast, by region

6.3.2.Market analysis, by country

CHAPTER 7:EQUINE HEALTHCARE MARKET, BY REGION

7.1.Overview

7.1.1.Market size and forecast

7.2.North America

7.2.1.Key market trends, growth factors, and opportunities

7.2.3.1.U.S.

7.2.3.1.1.U.S. Equine Healthcare market, by product type

7.2.3.1.2.U.S. Equine Healthcare market, by diseases

7.2.3.1.3.U.S. Equine Healthcare market, by distribution channel

7.2.3.2.Canada

7.2.3.2.1.Canada Equine Healthcare market, by product type

7.2.3.2.2.Canada Equine Healthcare market, by diseases

7.2.3.2.3.Canada Equine Healthcare market, by distribution channel

7.2.3.3.Mexico

7.2.3.3.1.Mexico Equine Healthcare market, by product type

7.2.3.3.2.Mexico Equine Healthcare market, by diseases

7.2.3.3.3.Mexico Equine Healthcare market, by distribution channel

7.2.4.North America market size and forecast, by product type

7.2.5.North America market size and forecast, by diseases

7.2.6.North America market size and forecast, by distribution channel

7.3.Europe

7.3.1.Key market trends, growth factors, and opportunities

7.3.2.Market size and forecast, by country

7.3.2.1.Germany

7.3.2.1.1.Germany Equine Healthcare market, by product type

7.3.2.1.2.Germany Equine Healthcare market, by diseases

7.3.2.1.3.Germany Equine Healthcare market, by distribution channel

7.3.2.2.France

7.3.2.2.1.France Equine Healthcare market, by product type

7.3.2.2.2.France Equine Healthcare market, by diseases

7.3.2.2.3.France Equine Healthcare market, by distribution channel

7.3.2.3.UK

7.3.2.3.1.UK Equine Healthcare market, by product type

7.3.2.3.2.UK Equine Healthcare market, by diseases

7.3.2.3.3.UK Equine Healthcare market, by distribution channel

7.3.2.4.Italy

7.3.2.4.1.Italy Equine Healthcare market, by product type

7.3.2.4.2.Italy Equine Healthcare market, by diseases

7.3.2.4.3.Italy Equine Healthcare market, by distribution channel

7.3.2.5.Spain

7.3.2.5.1.Spain Equine Healthcare market, by product type

7.3.2.5.2.Spain Equine Healthcare market, by diseases

7.3.2.5.3.Spain Equine Healthcare market, by distribution channel

7.3.2.6.Rest of Europe

7.3.2.6.1.Rest of Europe Equine Healthcare market, by product type

7.3.2.6.2.Rest of Europe Equine Healthcare market, by diseases

7.3.2.6.3.Rest of Europe Equine Healthcare market, by distribution channel

7.3.3.Europe market size and forecast, by product type

7.3.4.Europe market size and forecast, by diseases

7.3.5.Europe market size and forecast, by distribution channel

7.4.Asia-Pacific

7.4.1.Key market trends, growth factors, and opportunities

7.4.2.Market size and forecast, by country

7.4.2.1.Japan

7.4.2.1.1.Japan Equine Healthcare market, by product type

7.4.2.1.2.Japan Equine Healthcare market, by diseases

7.4.2.1.3.Japan Equine Healthcare market, by distribution channel

7.4.2.2.China

7.4.2.2.1.China Equine Healthcare market, by product type

7.4.2.2.2.China Equine Healthcare market, by diseases

7.4.2.2.3.China Equine Healthcare market, by distribution channel

7.4.2.3.Australia

7.4.2.3.1.Australia Equine Healthcare market, by product type

7.4.2.3.2.Australia Equine Healthcare market, by diseases

7.4.2.3.3.Australia Equine Healthcare market, by distribution channel

7.4.2.4.India

7.4.2.4.1.India Equine Healthcare market, by product type

7.4.2.4.2.India Equine Healthcare market, by diseases

7.4.2.4.3.India Equine Healthcare market, by distribution channel

7.4.2.5.South Korea

7.4.2.5.1.South Korea Equine Healthcare market, by product type

7.4.2.5.2.South Korea Equine Healthcare market, by diseases

7.4.2.5.3.South Korea Equine Healthcare market, by distribution channel

7.4.2.6.Rest of Asia-Pacific

7.4.2.6.1.Rest of Asia-Pacific Equine Healthcare market, by product type

7.4.2.6.2.Rest of Asia-Pacific Equine Healthcare market, by diseases

7.4.2.6.3.Rest of Asia-Pacific Equine Healthcare market, by distribution channel

7.4.3.Asia-Pacific market size and forecast, by product type

7.4.4.Asia-Pacific market size and forecast, by diseases

7.4.5.Asia-Pacific market size and forecast, by distribution channel

7.5.LAMEA

7.5.1.Key market trends, growth factors, and opportunities

7.5.2.Market size and forecast, by country

7.5.2.1.Brazil

7.5.2.1.1.Brazil Equine Healthcare market, by product type

7.5.2.1.2.Brazil Equine Healthcare market, by diseases

7.5.2.1.3.Brazil Equine Healthcare market, by distribution channel

7.5.2.2.Saudi Arabia

7.5.2.2.1.Saudi Arabia Equine Healthcare market, by product type

7.5.2.2.2.Saudi Arabia Equine Healthcare market, by diseases

7.5.2.2.3.Saudi Arabia Equine Healthcare market, by distribution channel

7.5.2.3.South Africa

7.5.2.3.1.South Africa Equine Healthcare market, by product type

7.5.2.3.2.South Africa Equine Healthcare market, by diseases

7.5.2.3.3.South Africa Equine Healthcare market, by distribution channel

7.5.2.4.Rest of LAMEA

7.5.2.4.1.Rest of LAMEA Equine Healthcare market, by product type

7.5.2.4.2.Rest of LAMEA Equine Healthcare market, by diseases

7.5.2.4.3.Rest of LAMEA Equine Healthcare market, by distribution channel

7.5.3.LAMEA market size and forecast, by product type

7.5.4.LAMEA market size and forecast, by diseases

7.5.5.LAMEA market size and forecast, by distribution channel

CHAPTER 8:COMPANY PROFILES

8.1.Boehringer Ingelheim International GmbH

8.1.1.Company overview

8.1.2.Company snapshot

8.1.3.Operating business segments

8.1.4.Product portfolio

8.1.5.Key strategic moves and developments

8.2.Ceva Santé Animale

8.2.1.Company overview

8.2.2.Company snapshot

8.2.3.Operating business segments

8.2.4.Product portfolio

8.3.Elanco Animal Health Inc. (Bayer Animal Health)

8.3.1.Company overview

8.3.2.Company snapshot

8.3.3.Operating business segments

8.3.4.Product portfolio

8.3.5.Business performance

8.3.6.Key strategic moves and developments

8.4.Equine Products UK LTD

8.4.1.Company overview

8.4.2.Company snapshot

8.4.3.Operating business segments

8.4.4.Product portfolio

8.4.5.Key strategic moves and developments

8.5.Land O'Lakes, Inc. (Purina Mills, LLC)

8.5.1.Company overview

8.5.2.Company snapshot

8.5.3.Operating business segments

8.5.4.Product portfolio

8.6.MERCK & CO., INC.(Merck Animal Health)

8.6.1.Company overview

8.6.2.Company snapshot

8.6.3.Operating business segments

8.6.4.Product portfolio

8.6.5.Business performance

8.7.Sanofi S.A. (Merial)

8.7.1.Company overview

8.7.2.Company snapshot

8.7.3.Operating business segments

8.7.4.Product portfolio

8.7.5.Business performance

8.8.Thermo Fisher Scientific Inc. (Affymetrix Inc.)

8.8.1.Company overview

8.8.2.Company snapshot

8.8.3.Operating business segments

8.8.4.Product portfolio

8.8.5.Business performance

8.9.Vetoquinol S.A.

8.9.1.Company overview

8.9.2.Company snapshot

8.9.3.Operating business segments

8.9.4.Product portfolio

8.9.5.Business performance

8.10.Zoetis Inc.

8.10.1.Company overview

8.10.2.Company snapshot

8.10.3.Operating business segments

8.10.4.Product portfolio

8.10.5.Business performance

8.10.6.Key strategic moves and developments

TABLE 01.EQUINE HEALTHCARE MARKET, BY PRODUCT, 2020-2030 ($MILLION)

TABLE 02.EQUINE HEALTHCARE MARKET FOR DRUGS, BY REGION, 2020-2030 ($MILLION)

TABLE 03.EQUINE HEALTHCARE MARKET FOR VACCINES, BY REGION, 2020-2030 ($MILLION)

TABLE 04.EQUINE HEALTHCARE MARKET FOR MEDICATED FEED ADDITVES, BY REGION, 2020-2030 ($MILLION)

TABLE 05.EQUINE HEALTHCARE MARKET, BY DISEASES, 2020-2030 ($MILLION)

TABLE 06.EQUINE HEALTHCARE MARKET FOR INFLUENZA, BY REGION, 2020-2030 ($MILLION)

TABLE 07.EQUINE HEALTHCARE MARKET FOR TETANUS, BY REGION, 2020-2030 ($MILLION)

TABLE 08.EQUINE HEALTHCARE MARKET FOR EQUINE HERPES VIRUS, BY REGION, 2020-2030 ($MILLION)

TABLE 09.EQUINE HEALTHCARE MARKET FOR OTHER DISEASES, BY REGION, 2020-2030 ($MILLION)

TABLE 10.EQUINE HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2020-2030 ($MILLION)

TABLE 11.EQUINE HEALTHCARE MARKET FOR VETERINARY HOSPITALS AND CLINICS, BY REGION, 2020-2030 ($MILLION)

TABLE 12.EQUINE HEALTHCARE MARKET FOR RETAIL PHARMACIES AND DRUG STORES, BY REGION, 2020-2030 ($MILLION)

TABLE 13.EQUINE HEALTHCARE MARKET, BY REGION, 2020–2030 ($MILLION)

TABLE 16.U.S. EQUINE HEALTHCARE MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)

TABLE 17.U.S. EQUINE HEALTHCARE MARKET, BY DISEASES, 2020–2030 ($MILLION)

TABLE 18.U.S. EQUINE HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2020–2030 ($MILLION)

TABLE 19.CANADA EQUINE HEALTHCARE MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)

TABLE 20.CANADA EQUINE HEALTHCARE MARKET, BY DISEASES, 2020–2030 ($MILLION)

TABLE 21.CANADA EQUINE HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2020–2030 ($MILLION)

TABLE 22.MEXICO EQUINE HEALTHCARE MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)

TABLE 23.MEXICO EQUINE HEALTHCARE MARKET, BY DISEASES, 2020–2030 ($MILLION)

TABLE 24.MEXICO EQUINE HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2020–2030 ($MILLION)

TABLE 25.NORTH AMERICA EQUINE HEALTHCARE MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)

TABLE 26.NORTH AMERICA EQUINE HEALTHCARE MARKET, BY DISEASES, 2020–2030 ($MILLION)

TABLE 27.NORTH AMERICA EQUINE HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2020–2030 ($MILLION)

TABLE 28.EUROPE EQUINE HEALTHCARE MARKET, BY COUNTRY, 2020–2030 ($MILLION)

TABLE 29.GERMANY EQUINE HEALTHCARE MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)

TABLE 30.GERMANY EQUINE HEALTHCARE MARKET, BY DISEASES, 2020–2030 ($MILLION)

TABLE 31.GERMANY EQUINE HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2020–2030 ($MILLION)

TABLE 32.FRANCE EQUINE HEALTHCARE MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)

TABLE 33.FRANCE EQUINE HEALTHCARE MARKET, BY DISEASES, 2020–2030 ($MILLION)

TABLE 34.FRANCE EQUINE HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2020–2030 ($MILLION)

TABLE 35.UK EQUINE HEALTHCARE MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)

TABLE 36.UK EQUINE HEALTHCARE MARKET, BY DISEASES, 2020–2030 ($MILLION)

TABLE 37.UK EQUINE HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2020–2030 ($MILLION)

TABLE 38.ITALY EQUINE HEALTHCARE MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)

TABLE 39.ITALY EQUINE HEALTHCARE MARKET, BY DISEASES, 2020–2030 ($MILLION)

TABLE 40.ITALY EQUINE HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2020–2030 ($MILLION)

TABLE 41.SPAIN EQUINE HEALTHCARE MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)

TABLE 42.SPAIN EQUINE HEALTHCARE MARKET, BY DISEASES, 2020–2030 ($MILLION)

TABLE 43.SPAIN EQUINE HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2020–2030 ($MILLION)

TABLE 44.REST OF EUROPE EQUINE HEALTHCARE MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)

TABLE 45.REST OF EUROPE EQUINE HEALTHCARE MARKET, BY DISEASES, 2020–2030 ($MILLION)

TABLE 46.REST OF EUROPE EQUINE HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2020–2030 ($MILLION)

TABLE 47.EUROPE EQUINE HEALTHCARE MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)

TABLE 48.EUROPE EQUINE HEALTHCARE MARKET, BY DISEASES, 2020–2030 ($MILLION)

TABLE 49.EUROPE EQUINE HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2020–2030 ($MILLION)

TABLE 50.ASIA-PACIFIC EQUINE HEALTHCARE MARKET, BY COUNTRY, 2020–2030 ($MILLION)

TABLE 51.JAPAN EQUINE HEALTHCARE MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)

TABLE 52.JAPAN EQUINE HEALTHCARE MARKET, BY DISEASES, 2020–2030 ($MILLION)

TABLE 53.JAPAN EQUINE HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2020–2030 ($MILLION)

TABLE 54.CHINA EQUINE HEALTHCARE MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)

TABLE 55.CHINA EQUINE HEALTHCARE MARKET, BY DISEASES, 2020–2030 ($MILLION)

TABLE 56.CHINA EQUINE HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2020–2030 ($MILLION)

TABLE 57.AUSTRALIA EQUINE HEALTHCARE MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)

TABLE 58.AUSTRALIA EQUINE HEALTHCARE MARKET, BY DISEASES, 2020–2030 ($MILLION)

TABLE 59.AUSTRALIA EQUINE HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2020–2030 ($MILLION)

TABLE 60.INDIA EQUINE HEALTHCARE MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)

TABLE 61.INDIA EQUINE HEALTHCARE MARKET, BY DISEASES, 2020–2030 ($MILLION)

TABLE 62.INDIA EQUINE HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2020–2030 ($MILLION)

TABLE 63.SOUTH KOREA EQUINE HEALTHCARE MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)

TABLE 64.SOUTH KOREA EQUINE HEALTHCARE MARKET, BY DISEASES, 2020–2030 ($MILLION)

TABLE 65.SOUTH KOREA EQUINE HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2020–2030 ($MILLION)

TABLE 66.REST OF ASIA-PACIFIC EQUINE HEALTHCARE MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)

TABLE 67.REST OF ASIA-PACIFIC EQUINE HEALTHCARE MARKET, BY DISEASES, 2020–2030 ($MILLION)

TABLE 68.REST OF ASIA-PACIFIC EQUINE HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2020–2030 ($MILLION)

TABLE 69.ASIA-PACIFIC EQUINE HEALTHCARE MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)

TABLE 70.ASIA-PACIFIC EQUINE HEALTHCARE MARKET, BY DISEASES, 2020–2030 ($MILLION)

TABLE 71.ASIA-PACIFIC EQUINE HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2020–2030 ($MILLION)

TABLE 72.LAMEA EQUINE HEALTHCARE MARKET, BY COUNTRY, 2020–2030 ($MILLION)

TABLE 73.BRAZIL EQUINE HEALTHCARE MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)

TABLE 74.BRAZIL EQUINE HEALTHCARE MARKET, BY DISEASES, 2020–2030 ($MILLION)

TABLE 75.BRAZIL EQUINE HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2020–2030 ($MILLION)

TABLE 76.SAUDI ARABIA EQUINE HEALTHCARE MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)

TABLE 77.SAUDI ARABIA EQUINE HEALTHCARE MARKET, BY DISEASES, 2020–2030 ($MILLION)

TABLE 78.SAUDI ARABIA EQUINE HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2020–2030 ($MILLION)

TABLE 79.SOUTH AFRICA EQUINE HEALTHCARE MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)

TABLE 80.SOUTH AFRICA EQUINE HEALTHCARE MARKET, BY DISEASES, 2020–2030 ($MILLION)

TABLE 81.SOUTH AFRICA EQUINE HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2020–2030 ($MILLION)

TABLE 82.REST OF LAMEA EQUINE HEALTHCARE MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)

TABLE 83.REST OF LAMEA EQUINE HEALTHCARE MARKET, BY DISEASES, 2020–2030 ($MILLION)

TABLE 84.REST OF LAMEA EQUINE HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2020–2030 ($MILLION)

TABLE 85.LAMEA EQUINE HEALTHCARE MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)

TABLE 86.LAMEA EQUINE HEALTHCARE MARKET, BY DISEASES, 2020–2030 ($MILLION)

TABLE 87.LAMEA EQUINE HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2020–2030 ($MILLION)

TABLE 88.BOEHRINGER INGELHEIM: COMPANY SNAPSHOT

TABLE 89.BOEHRINGER INGELHEIM: OPERATING SEGMENTS

TABLE 90.BOEHRINGER INGELHEIM: PRODUCT PORTFOLIO

TABLE 91.BOEHRINGER INGELHEIM: KEY STRATEGIC MOVES AND DEVELOPMENTS

TABLE 92.CEVA SANTÉ: COMPANY SNAPSHOT

TABLE 93.CEVA SANTÉ: OERATING SEGMENT

TABLE 94.CEVA SANTÉ: PRODUCT PORTFOLIO

TABLE 95.ELANCO: COMPANY SNAPSHOT

TABLE 96.ELANCO: OPERATING SEGMENTS

TABLE 97.ELANCO: PRODUCT PORTFOLIO

TABLE 98.ELANCO: KEY STRATEGIC MOVES AND DEVELOPMENTS

TABLE 99.EQUINE PRODUCTS: COMPANY SNAPSHOT

TABLE 100.EQUINE PRODUCTS: OPERATING SEGMENTS

TABLE 101.EQUINE PRODUCTS: PRODUCT PORTFOLIO

TABLE 102.EQUINE PRODUCTS: KEY STRATEGIC MOVES AND DEVELOPMENTS

TABLE 103.LAND O'LAKES: COMPANY SNAPSHOT

TABLE 104.LAND O'LAKES: OPERATING SEGMENTS

TABLE 105.LAND O'LAKES: PRODUCT PORTFOLIO

TABLE 106.MERCK: COMPANY SNAPSHOT

TABLE 107.MERCK: OPERATING SEGMENTS

TABLE 108.MERCK: PRODUCT PORTFOLIO

TABLE 109.SANOFI: COMPANY SNAPSHOT

TABLE 110.SANOFI: OERATING SEGMENT

TABLE 111.SANOFI: PRODUCT PORTFOLIO

TABLE 112.THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT

TABLE 113.THERMO FISHER SCIENTIFIC: OERATING SEGMENT

TABLE 114.THERMO FISHER SCIENTIFIC: PRODUCT PORTFOLIO

TABLE 115.VETOQUINOL: COMPANY SNAPSHOT

TABLE 116.VETOQUINOL: OPERATING SEGMENTS

TABLE 117.VETOQUINOL: PRODUCT PORTFOLIO

TABLE 118.ZOETIS: COMPANY SNAPSHOT

TABLE 119.ZOETIS: OPERATING SEGMENTS

TABLE 120.ZOETIS: PRODUCT PORTFOLIO

TABLE 121.ZOETIS: KEY STRATEGIC MOVES AND DEVELOPMENTS